Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Research indicates that acute hepatocellular injury in cholelithiasis and cholecystitis without choledocholithiasis is mild and transient

Research indicates that acute hepatocellular injury in cholelithiasis and cholecystitis without choledocholithiasis is mild and transient

Study suggests that connective tissue growth factor plays a vital role in liver fibrosis progression

Study suggests that connective tissue growth factor plays a vital role in liver fibrosis progression

USPTO grants MultiCell Technologies patent for its Fa2N-4 and Ea1C-35 immortalized human hepatocyte cell lines

USPTO grants MultiCell Technologies patent for its Fa2N-4 and Ea1C-35 immortalized human hepatocyte cell lines

4SC starts phase 2 trial in hepatocellular carcinoma with 4SC-201 (resminostat)

4SC starts phase 2 trial in hepatocellular carcinoma with 4SC-201 (resminostat)

New biomarker predicts response to hepatitis C treatment

New biomarker predicts response to hepatitis C treatment

Giant pituitary adenoma can be safely removed through nasal route

Giant pituitary adenoma can be safely removed through nasal route

Predictors of disease behavior change in patients with Crohn's disease

Predictors of disease behavior change in patients with Crohn's disease

Characteristic pathological findings and effects of ecabet sodium in rat reflux esophagitis

Characteristic pathological findings and effects of ecabet sodium in rat reflux esophagitis

Metabolic bone disease in cirrhosis patients

Metabolic bone disease in cirrhosis patients

Gallbladder emptying in primary sclerosing cholangitis patients

Gallbladder emptying in primary sclerosing cholangitis patients

Discovery of 'marker' molecule offers hope for liver cancer test

Discovery of 'marker' molecule offers hope for liver cancer test

Moving to U.S. increases cancer risk for Hispanics

Moving to U.S. increases cancer risk for Hispanics

Jefferson names endowed Professorship in transplant surgery

Jefferson names endowed Professorship in transplant surgery

Heavy drinkers have much higher risk of developing cancer

Heavy drinkers have much higher risk of developing cancer

Heavy consumption of beer and spirits to 6 different cancers

Heavy consumption of beer and spirits to 6 different cancers

Mortality rates higher in hepatitis C virus carriers

Mortality rates higher in hepatitis C virus carriers

Hepatitis C infection:  Treatment options equally effective, likelihood of success known early on

Hepatitis C infection: Treatment options equally effective, likelihood of success known early on

Focusing HIV treatment helps control concurrent hepatitis B infection

Focusing HIV treatment helps control concurrent hepatitis B infection

Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy

Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy

Discovery of potent metastasis inhibitor

Discovery of potent metastasis inhibitor

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.